Medication Discontinuation in the IMPROVE-IT Trial-Reference-Cited by-同舟云学术

Medication Discontinuation in the IMPROVE-IT Trial

Published:2019-01 Issue:1 Volume:12 Page:
ISSN:1941-7713
Container-title:Circulation: Cardiovascular Quality and Outcomes
language:en
Short-container-title:Circ Cardiovasc Qual Outcomes

Author:

Navar Ann Marie¹²,Roe Matthew T.¹,White Jennifer A.¹,Cannon Christopher P.³,Lokhnygina Yuliya¹,Newby L. Kristin¹,Giugliano Robert P.¹³,Tershakovec Andrew M.⁴,Braunwald Eugene³,Califf Robert M.²⁵⁶,Blazing Michael A.¹

Affiliation:

1. Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (A.M.N., M.T.R., J.A.W., Y.L., L.K.N., M.A.B.).

2. Duke Forge, Duke University, Durham, NC (A.M.N., R.M.C.).

3. TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston, MA (C.P.C., R.P.G., E.B.).

4. Merck & Co, Inc, Rahway, NJ (A.M.T.).

5. Department of Medicine, Stanford University, CA (R.M.C.).

6. Verily Life Sciences, South San Francisco, CA (R.M.C.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference32 articles.

1. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

2. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

3. Beyond Medication Prescription as Performance Measures

4. Racial/Ethnic and Gender Gaps in the Use of and Adherence to Evidence-Based Preventive Therapies Among Elderly Medicare Part D Beneficiaries After Acute Myocardial Infarction

5. Impact of Medication Therapy Discontinuation on Mortality After Myocardial Infarction

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating underlying molecular mechanisms, signaling pathways, emerging therapeutic approaches in pancreatic cancer;Frontiers in Oncology;2024-07-17

2. Measuring the Influence of Side Effect Expectations, Beliefs, and Incident Side Effects on the Risk for Drug Discontinuation Among Individuals Starting New Medications, a Cross-sectional Study;Patient Preference and Adherence;2024-05

3. Lipid-Lowering Therapy after Acute Coronary Syndrome;Journal of Clinical Medicine;2024-04-01

4. Lipid-lowering approaches to manage statin-intolerant patients;European Heart Journal Supplements;2024-04

5. Measuring the influence of expectations, beliefs, and medication side effects on the risk for drug discontinuation among individuals starting new medications;2023-09-19